These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6734051)

  • 1. Effects of propranolol and of verapamil on heart rate and blood pressure in hyperthyroidism.
    Clozel JP; Danchin N; Genton P; Thomas JL; Cherrier F
    Clin Pharmacol Ther; 1984 Jul; 36(1):64-9. PubMed ID: 6734051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of potential pharmacodynamic and pharmacokinetic interactions between verapamil and propranolol in normal subjects.
    Murdoch DL; Thomson GD; Thompson GG; Murray GD; Brodie MJ; McInnes GT
    Br J Clin Pharmacol; 1991 Mar; 31(3):323-32. PubMed ID: 2054272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of propranolol and verapamil on hyperthyroid heart symptoms and function, assessed by systolic time intervals.
    Nordin H; Galløe AM; Ladefoged SD; Badskjaer J
    Acta Endocrinol (Copenh); 1993 Apr; 128(4):297-300. PubMed ID: 8498148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between oral verapamil and beta-blockers during submaximal exercise: relevance of ancillary properties.
    Bailey DG; Carruthers SG
    Clin Pharmacol Ther; 1991 Apr; 49(4):370-6. PubMed ID: 2015727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of propranolol, verapamil and dantrolene treatment on cardiac hypertrophy, enhanced myocardial contractility and tachycardia in the hyperthyroid rat.
    Wheatley AM; Butkow N; Grote J; Musiker J; Rosendorff C
    Pharmacol Res; 1990; 22(3):307-18. PubMed ID: 2142279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular depression by verapamil: reversal by glucagon and interactions with propranolol.
    Jolly SR; Kipnis JN; Lucchesi BR
    Pharmacology; 1987; 35(5):249-55. PubMed ID: 3423100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular action of verapamil in the dog with particular reference to myocardial contractility and atrioventricular conduction.
    Angus JA; Richmond DR; Dhumma-Upakorn P; Cobbin LB; Goodman AH
    Cardiovasc Res; 1976 Nov; 10(6):623-32. PubMed ID: 991162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of verapamil and beta blockers in systemic hypertension.
    Dargie H; Cleland J; Findlay I; Murray G; McInnes G
    Am J Cardiol; 1986 Feb; 57(7):80D-82D. PubMed ID: 3513518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verapamil and propranolol: a comparison of two antihypertensive agents.
    Leonetti G; Pasotti C; Ferrari GP; Zanchetti A
    Acta Med Scand Suppl; 1984; 681():137-41. PubMed ID: 6587752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of captopril, propranolol, and verapamil on arterial pulse wave velocity and other cardiovascular parameters in healthy volunteers.
    Kähönen M; Ylitalo R; Kööbi T; Turjanmaa V; Ylitalo P
    Int J Clin Pharmacol Ther; 1998 Sep; 36(9):483-9. PubMed ID: 9760009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of verapamil on electrophysiologic properties of blood superfused cardiac Purkinje fibers.
    Danilo P; Hordof AJ; Reder RF; Rosen MR
    J Pharmacol Exp Ther; 1980 May; 213(2):222-7. PubMed ID: 7365685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of propranolol on heart rate variability in hyperthyroidism.
    Tankeu AT; Azabji-Kenfack M; Nganou CN; Ngassam E; Kuate-Mfeukeu L; Mba C; Dehayem MY; Mbanya JC; Sobngwi E
    BMC Res Notes; 2018 Feb; 11(1):151. PubMed ID: 29471876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects of verapamil and propranolol during submaximal endurance exercise in patients with essential hypertension.
    van Baak MA; Böhm RO; Petri J; Rahn KH
    Int J Sports Med; 1987 Aug; 8(4):270-4. PubMed ID: 3667024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactive negative chronotropic actions of adenosine and verapamil on the canine sinus node in vivo.
    Pelleg A; Mitamura H; Mitsuoka T; Mazgalev T; Michelson EL; Dreifus LS
    Prog Clin Biol Res; 1987; 230():235-52. PubMed ID: 3588599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of propranolol and verapamil on atrial and atrioventricular refractory periods in man.
    Silvertssen E; Bay G; Grendahl H
    Angiology; 1975 Sep; 26(8):605-18. PubMed ID: 1053603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA; Chou TC; Lin KC
    J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verapamil and propranolol in essential hypertension.
    Halperin AK; Gross KM; Rogers JF; Cubeddu LX
    Clin Pharmacol Ther; 1984 Dec; 36(6):750-8. PubMed ID: 6499355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of oral nitrendipine and propranolol, alone and in combination, on hypertensive patients with special reference to AV conduction.
    Maltz MB; Davies DW; Lau CP; Creamer JE; Banim SO; Camm AJ
    Br J Clin Pharmacol; 1986 Oct; 22(4):463-7. PubMed ID: 3533128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular responses to verapamil and propranolol in hypertensive patients.
    McInnes GT; Findlay IN; Murray G; Cleland JG; Dargie HJ
    J Hypertens Suppl; 1985 Dec; 3(3):S219-21. PubMed ID: 2856708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of verapamil on cardiac chronotropic response to vagal stimulation in neonatal pigs.
    Lee JC; McGrath CJ; Kornegay ET
    Am J Vet Res; 1985 Feb; 46(2):466-9. PubMed ID: 3994114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.